Pancreatic cancer-associated thrombosis

• Published in: Hong Kong medical journal = Xianggang yi xue za zhi Vol. 29; no. 5; p. 378
• Main Authors: Tam, T H C, Lui, R N
• Format: Journal Article
• Language: English
• Published: China Hong Kong Academy of Medicine 01.10.2023
• Subjects: Anticoagulants; Cancer therapies; Clinical medicine; Clinical practice guidelines; Disease prevention; Epidemiology; Gastroenterology; Hematology; Hepatology; Hospitals; Humans; Medical prognosis; Medicine; Oncology; Pancreatic cancer; Pancreatic Neoplasms; Pancreatic Neoplasms - complications; Pathogenesis; Thromboembolism; Thrombosis; Thrombosis - diagnostic imaging; Thrombosis - etiology; Hong Kong China; United Kingdom > UK; China; Wales
• ISSN: 1024-2708; 2226-8707
• DOI: 10.12809/hkmj235151

CC BY-NC-ND 4.0 EDITORIAL Pancreatic cancer[-]associated thrombosis Tommy HC Tam, FRCP (Glasg), FHKAM (Medicine)1; Rashid N Lui, FRCP (Lond), FHKAM (Medicine)2,3 1 Division of Haematology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong SAR, China 2 Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong SAR, China 3 Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China Corresponding author: Dr Tommy HC Tam (tommytam@cuhk.edu.hk) Full paper in PDF Malignancy is a well-known cause of clinically significant vascular thrombosis, associated with a 7- to 28-fold increase in the risk of venous thromboembolism across all cancers.1 Pancreatic cancer is among several malignancies with the highest risk of cancer-associated thrombosis (CAT).2 Nevertheless, current knowledge of CAT is mostly extrapolated from studies involving Western populations. [...]meaningful insights could be gained by investigating the effects of various pharmacological treatments on patient-reported quality of life measures.